Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease. (Q53408592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

title

Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

main subject

inflammation

0 references

hepatocellular carcinoma

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

Francesca Romana Ponziani

inferred from title

author

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Licia Rivoltini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Federica Del Chierico

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Maurizio Sanguinetti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

Francesco Paroni Sterbini

23 March 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Valentina Petito

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Riccardo Calvani

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Anna Picca

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Vincenzo Mazzaferro

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

4

Lorenza Putignani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Sherrie Bhoori

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Chiara Castelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Daniele Morelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Sofia Reddel

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Chiara Camisaschi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Alessandra Tuccitto

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Antonio Gasbarrini

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Maurizio Pompili

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

language of work or name

English

0 references

publication date

10 July 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

107-120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

cites work

Hepatocellular carcinoma

1 reference

7 January 2021

Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents

1 reference

7 January 2021

Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

1 reference

7 January 2021

Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats.

1 reference

7 January 2021

Myeloid cells in hepatocellular carcinoma

1 reference

7 January 2021

Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma

1 reference

7 January 2021

Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice

1 reference

7 January 2021

Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.

1 reference

7 January 2021

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

1 reference

7 January 2021

Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis.

1 reference

7 January 2021

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

7 January 2021

The Gordian Knot of dysbiosis, obesity and NAFLD.

1 reference

7 January 2021

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

1 reference

7 January 2021

The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.

1 reference

7 January 2021

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

1 reference

7 January 2021

Metagenomic biomarker discovery and explanation

1 reference

7 January 2021

Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis

1 reference

7 January 2021

Low-grade endotoxemia and platelet activation in cirrhosis

1 reference

7 January 2021

Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis

1 reference

7 January 2021

Functional role of CCL5/RANTES for HCC progression during chronic liver disease.

1 reference

7 January 2021

Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma

1 reference

7 January 2021

Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression

1 reference

7 January 2021

Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas

1 reference

7 January 2021

Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice

1 reference

7 January 2021

Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress

1 reference

7 January 2021

Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model.

1 reference

7 January 2021

A new HIF-1α/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice

1 reference

7 January 2021

Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells

1 reference

7 January 2021

TLR4 enhances TGF-beta signaling and hepatic fibrosis

1 reference

7 January 2021

Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.

1 reference

7 January 2021

Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins.

1 reference

7 January 2021

Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma

1 reference

7 January 2021

TLR4-Dependent Secretion by Hepatic Stellate Cells of the Neutrophil-Chemoattractant CXCL1 Mediates Liver Response to Gut Microbiota.

1 reference

7 January 2021

Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).

1 reference

7 January 2021

Protective and pathogenic functions of macrophage subsets

1 reference

7 January 2021

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus

1 reference

7 January 2021

Alterations of the human gut microbiome in liver cirrhosis

1 reference

7 January 2021

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

1 reference

7 January 2021

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

1 reference

7 January 2021

Protective Effect of Akkermansia muciniphila against Immune-Mediated Liver Injury in a Mouse Model.

1 reference

7 January 2021

Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota

1 reference

7 January 2021

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy

1 reference

7 January 2021

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.

1 reference

7 January 2021

PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment.

1 reference

7 January 2021

Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells.

1 reference

7 January 2021

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review

1 reference

7 January 2021

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.30036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29665135%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference